The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Economic Costs of Diabetes in the U.S. in 2007
Open accessAbstract
OBJECTIVE—The prevalence of diabetes continues to grow, with the number of people in the U.S. with diagnosed diabetes now reaching 17.5 million. The objectives of this study are to quantify the economic burden of diabetes caused by increased health resource use and lost productivity, and to provide a detailed breakdown of the costs attributed to diabetes. RESEARCH DESIGN AND METHODS—This study uses a prevalence-based approach that combines the demographics of the population in 2007 with diabetes prevalence rates and other epidemiological data, health care costs, and economic data into a Cost of Diabetes Model. Health resource use and associated medical costs are analyzed by age, sex, type of medical condition, and health resource category. Data sources include national surveys and claims databases, as well as a proprietary database that contains annual medical claims for 16.3 million people in 2006. RESULTS—The total estimated cost of diabetes in 2007 is $174 billion, including $116 billion in excess medical expenditures and $58 billion in reduced national productivity. Medical costs attributed to diabetes include $27 billion for care to directly treat diabetes, $58 billion to treat the portion of diabetes-related chronic complications that are attributed to diabetes, and $31 billon in excess general medical costs. The largest components of medical expenditures attributed to diabetes are hospital inpatient care (50% of total cost), diabetes medication and supplies (12%), retail prescriptions to treat complications of diabetes (11%), and physician office visits (9%). People with diagnosed diabetes incur average expenditures of $11,744 per year, of which $6,649 is attributed to diabetes. People with diagnosed diabetes, on average, have medical expenditures that are ∼2.3 times higher than what expenditures would be in the absence of diabetes. For the cost categories analyzed, ∼$1 in $5 health care dollars in the U.S. is spent caring for someone with diagnosed diabetes, while ∼$1 in $10 health care dollars is attributed to diabetes. Indirect costs include increased absenteeism ($2.6 billion) and reduced productivity while at work ($20.0 billion) for the employed population, reduced productivity for those not in the labor force ($0.8 billion), unemployment from disease-related disability ($7.9 billion), and lost productive capacity due to early mortality ($26.9 billion). CONCLUSIONS—The actual national burden of diabetes is likely to exceed the $174 billion estimate because it omits the social cost of intangibles such as pain and suffering, care provided by nonpaid caregivers, excess medical costs associated with undiagnosed diabetes, and diabetes-attributed costs for health care expenditures categories omitted from this study. Omitted from this analysis are expenditure categories such as health care system administrative costs, over-the-counter medications, clinician training programs, and research and infrastructure development. The burden of diabetes is imposed on all sectors of society—higher insurance premiums paid by employees and employers, reduced earnings through productivity loss, and reduced overall quality of life for people with diabetes and their families and friends.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persons with diabetes are three times more likely to be hospitalized than those without diabetes, and approximately 25% of hospitalized patients (including people without a history of diabetes) have hyperglycemia (62–65).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Persons with diabetes are three times more likely to be hospitalized than those without diabetes, and approximately 25% of hospitalized patients (including people without a history of diabetes) have hyperglycemia (62–65).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [62]
Experimental — accuracy not yet measuredIn the citing paper
“Persons with diabetes are three times more likely to be hospitalized than those without diabetes, and approximately 25% of hospitalized patients (including people without a history of diabetes) have hyperglycemia (62 -65).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [62]
In the citing paper
“Persons with diabetes are three times more likely to be hospitalized than those without diabetes, and approximately 25% of hospitalized patients (including people without a history of diabetes) have hyperglycemia (62 -65).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [62]
In the citing paper
“Yet at least 25% of subjects with T2DM are undiagnosed, 18 and they are often concentrated within a hypertriglyceridemic population.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Self-citationGoetzel, R. Z., Long, S. R., Ozminkowski, R. J., Hawkins, K., Wang, S., & Lynch, W. (2004) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000121151.40413.bd · Cited by 1,259
Okura, Y., Urban, L. H., Mahoney, D. W., Jacobsen, S. J., & Rodeheffer, R. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.04.005 · Cited by 1,254
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Eberhardt, M. S., Flegal, K. M., Engelgau, M. M., Saydah, S. H., Williams, D. E., Geiss, L. S., & Gregg, E. W. (2006) · Diabetes Care · doi:10.2337/dc06-0062 · Cited by 1,210
The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.
Gordois, A., Scuffham, P., Shearer, A. T., Oglesby, A. K., & Tobian, J. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1790 · Cited by 735
Goetzel, R. Z., Hawkins, K., Ozminkowski, R. J., & Wang, S. S. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200301000-00007 · Cited by 694
Economic Consequences of Diabetes Mellitus in the U.S. in 1997
American Diabetes Association (1998) · Diabetes Care · doi:10.2337/diacare.21.2.296 · Cited by 654
Self-citationImpact of Recent Increase in Incidence on Future Diabetes Burden
Narayan, K. M. V., Boyle, J. P., Geiss, L. S., Saaddine, J. B., & Thompson, T. J. (2006) · Diabetes Care · doi:10.2337/dc06-1136 · Cited by 602
Begley, C. E., Famulari, M., Annegers, J. F., Lairson, D. R., Reynolds, T. F., Coan, S. P., Dubinsky, S., Newmark, M. E., Leibson, C. L., So, E. L., et al. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00166.x · Cited by 599
A review of adjusted estimators of attributable risk
Bénichou, J. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000303 · Cited by 440
Flagged first, then by citations
Research works printed but not linked: 1
- Brown DA, Unrein C: A review of cardiovascular comorbidities of diabetes. Am J Managed Care 13:3–10, 2007
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Lakey, J. R. T., Botvinick, E. L., & Najdahmadi, A. (2018) · Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications · doi:10.1117/12.2318565 · Cited by 10
Prediction on diabetes patient's hospital readmission rates
Sharma, A., Agrawal, P., Madaan, V., & Goyal, S. (2019) · International Conference on Advanced Informatics for Computing Research (ICAICR) · doi:10.1145/3339311.3339349 · Cited by 10
Wei, Y., Chen, Y., Zhao, Y., Rothman, R. L., Ming, J., Wang, L., Liu, X., Shi, L., & Xu, W. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001179 · Cited by 12
Initiating and Intensifying Insulin Therapy for Type 2 Diabetes: Why, When, and How
Cobble, M. E. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181966bf0 · Cited by 10
Zhao, Y. W., Ye, W., Le, T. K., Boye, K. S., Holcombe, J. H., & Swindle, R. W. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802706289 · Cited by 10
Bodnar, T. W., Iyengar, J. J., Patil, P. V., & Gianchandani, R. Y. (2016) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-016-0038-4 · Cited by 10
Therapeutic Apheresis in Metabolic Syndrome
Воинов, В. А. (2018) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/1871522218666180608114536 · Cited by 10
Burden of macro- and micro-vascular complications of type 2 diabetes in Bangladesh
Afroz, A., Alam, K., Hossain, M. N., Biswas, A., Ali, L., Magliano, D. J., & Billah, B. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.03.001 · Cited by 10
OECD (2010) · Health at a glance · doi:10.1787/9789264105133-ko · Cited by 11
(2009) · Health at a glance · doi:10.1787/health_glance-2009-37-en · Cited by 10
Epidemiology of Type 2 Diabetes
Ronald, C. W., & Tong, P. C. Y. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch5 · Cited by 10
Rao, A., Wiley, M., Iyengar, S., Nadeau, D., & Carnevale, J. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400118 · Cited by 12
Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
Valensi, P. E. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s3408 · Cited by 9
Time for Action: A Canadian Proposal for Primary Prevention of Type 2 Diabetes Mellitus
McManus, R. M. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.04.006 · Cited by 9
Huang, C., Ma, T., Tien, L., Hsieh, Y., Lee, S.-Y., Chen, H.-Y., & Jong, G. (2012) · BioMed Research International · doi:10.1155/2013/287696 · Cited by 9
Budget impact analysis of insulin therapies and associated delivery systems
Lee, L. J., Smolen, L. J., Klein, T. M., Foster, S. A., Whiteman, D., Jorgenson, J. A., & Hultgren, S. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110333 · Cited by 8
Kalkan, A., Bodegård, J., Sundström, J., Svennblad, B., Östgren, C. J., Nilsson, P. N., Johansson, G., & Ekman, M. (2016) · Primary care diabetes · doi:10.1016/j.pcd.2016.11.002 · Cited by 9
Rodríguez-Sánchez, B., Alessie, R. J. M., Feenstra, T., & Angelini, V. (2017) · The European Journal of Health Economics · doi:10.1007/s10198-017-0911-9 · Cited by 9
Coppell, K. J., Freer, T., Abel, S. L., Whitehead, L., Tipene‐Leach, D., Gray, A. R., Merriman, T. R., Sullivan, T. A., Krebs, J. D., & Perreault, L. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-033358 · Cited by 8
Diabetic Nephropathy: Scope of the Problem
Chen, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0793-9_2 · Cited by 9
Sylvia, M. L., Weiner, J. P., Nolan, M. T., Han, H., Brancati, F. L., & White, K. (2012) · Workplace Health & Safety · doi:10.1177/216507991206001004 · Cited by 9
Partnering with patients to promote holistic diabetes management: Changing paradigms
Lorenzo, L. (2013) · Journal of the American Association of Nurse Practitioners · doi:10.1111/1745-7599.12004 · Cited by 9
Self-Monitoring of Blood Glucose in Insulin-Requiring Type 2 Diabetes
Naik, R. G., & Ellis, S. L. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0030 · Cited by 9
Bergenstal, R. M., Fahrbach, J. L., Iorga, Ş. R., Fan, Y., & Foster, S. A. (2012) · Endocrine Practice · doi:10.4158/ep11166.or · Cited by 9
Liebl, A., Andersen, H., Svendsen, A. L., Vora, J. P., Yale, J., & the SOLVE Study Group (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12133 · Cited by 9
Direct medical cost of type 1 and type 2 diabetes in Turkey
Keşkek, Ş. Ö., Kırım, S., Yanmaz, N., Şahinoğlu-Keşkek, N., Ortoğlu, G., & Canataroğlu, A. (2013) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-013-0159-6 · Cited by 9
Lachamp, M., Pauly, V., Sambuc, R., Thirion, X., Potard, I., Molines, C., & Rétornaz, F. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.05.013 · Cited by 9
NÍVEL DE ATIVIDADE FÍSICA, POR ACELEROMETRIA, EM IDOSOS DO MUNICÍPIO DE SÃO PAULO: ESTUDO SABE
Bueno, D. R., Marucci, M. D. F. N., Roediger, M. D. A., Gomes, I. C., Duarte, Y. A. D. O., & Lebrão, M. L. (2016) · Revista Brasileira de Medicina do Esporte · doi:10.1590/1517-869220162202148501 · Cited by 9
Wang, J., Thomas, J. N., Byrd, D. C., Nola, K., & Liu, J. (2010) · Journal of the American Pharmacists Association · doi:10.1331/japha.2010.08173 · Cited by 9
Glycemic Management in the Inpatient Setting
Schmeltz, L. R., & Ferrise, C. (2012) · Hospital Practice · doi:10.3810/hp.2012.04.969 · Cited by 9
Development and Testing of the Insulin Treatment Experience Questionnaire (ITEQ)
Moock, J., Hessel, F. P., Ziegeler, D., Kubiak, T., & Kohlmann, T. (2010) · Patient · doi:10.2165/11319510-000000000-00000 · Cited by 9
Cost–effectiveness of insulin detemir: a systematic review
Suh, D., & Aagren, M. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.73 · Cited by 9
Is Depression a Modifiable Risk Factor for Diabetes Burden?
Molife, C. (2010) · Journal of Primary Care & Community Health · doi:10.1177/2150131909359633 · Cited by 9
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad079 · Cited by 8
Physician Preferences for Extra-Glycemic Effects of Type 2 Diabetes Treatments
Poulos, C. M., González, J. M., Lee, L. J., Boye, K., Johnson, F. R., Bae, J. P., & Deeg, M. A. (2013) · Diabetes Therapy · doi:10.1007/s13300-013-0046-7 · Cited by 8
Effectively Identifying the Inpatient With Hyperglycemia to Increase Patient Care and Lower Costs
Mabrey, M., McFarland, R., Young, S. L., Cooper, P. L., Chidester, P., & Rhinehart, A. S. (2014) · Hospital Practice · doi:10.3810/hp.2014.04.1098 · Cited by 8
Kim, S., Rushakoff, R. J., Sullivan, M. M., & MacMaster, H. W. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600622 · Cited by 8
Zhang, Q., Rajagopalan, S., Mavros, P., Engel, S. S., Davies, M. J., Yin, D., & Radican, L. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0024-7 · Cited by 8
Prihapsara, F., Harini, M., Widiyani, T., Artanti, A. N., & Ani, I. (2017) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/176/1/012004 · Cited by 8
Mirza, W., Saleem, M. S., Patel, G., Chacko, P., Reddy, S., Schaefer, R., Jones, R., Dheer, N., Dharampuri, S., & Sandhu, A. (2018) · Cureus · doi:10.7759/cureus.3641 · Cited by 8
RETRACTED: Application of embedded wearable devices in football training injury prevention
Song, H. (2021) · Microprocessors and Microsystems · doi:10.1016/j.micpro.2021.103915 · Cited by 8
RetractedHussein, M. H., Toraih, E. A., Reisner, A. S. C., Shihabi, A., Al‐Quaryshi, Z., Borchardt, J. A., & Kandil, E. H. (2022) · Gland Surgery · doi:10.21037/gs-21-648 · Cited by 8
van der Linden, M. W., Plat, A. W., Erkens, J. A., Emneus, M., & Herings, R. M. C. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00506.x · Cited by 8
Economic costs of diabetes in the US in 2007 — Implications for Europe
Bottomley, J. M. (2008) · The British Journal of Diabetes · doi:10.1177/14746514080080020801 · Cited by 8
Charles, M. S., Minshall, M. E., Pandya, B. J., Baran, R. W., & Tunis, S. L. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902870084 · Cited by 8
Examining the Use of Dietary Fiber in Reducing the Risk of Type 2 Diabetes Mellitus in Latino Youth
Pcsolyar, N. S., & Jonghe, B. C. D. (2013) · Journal of Transcultural Nursing · doi:10.1177/1043659613514115 · Cited by 8
Costs for Hospitalized Patients With Diabetes Mellitus in China
He, M., Ma, J., Wang, D. W., & Yu, X. (2012) · Asia Pacific Journal of Public Health · doi:10.1177/1010539512448813 · Cited by 8
Scenario-based user testing to guide consumer health informatics design.
Zayas‐Cabán, T., Marquard, J. L., Radhakrishnan, K., Duffey, N., & Evernden, D. L. (2009) · Europe PMC (PubMed Central) · Cited by 8
Preventive dental care in older adults with diabetes
Wiener, R. C., Shen, C., Sambamoorthi, N., & Sambamoorthi, U. (2016) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2016.03.022 · Cited by 8
Imam, S. K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00003-x · Cited by 8
Cornell, S. A. (2010) · Health Policy · doi:10.1016/j.healthpol.2010.02.006 · Cited by 8
Sacks, D. B. (2012) · Tietz Textbook of Clinical Chemistry and Molecular Diagnostics · doi:10.1016/b978-1-4160-6164-9.00046-9 · Cited by 7
Yosmar, R., SHEPANY, E., & Fitria, N. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024.v16s1.12 · Cited by 7
Yang, X., Peng, Z. Y., Liu, X., Liu, X., & Lu, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1332032 · Cited by 7
Pollock, R. F., Curtis, B. H., & Valentine, W. J. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.675890 · Cited by 7
Role of Innate Immune Cells in Chronic Diabetic Wounds
Raghavan, J. V., & Jhunjhunwala, S. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-022-00355-4 · Cited by 8
Bajwa, S. J., Baruah, M., Kalra, S., & Kapoor, M. (2015) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/0970-9185.155141 · Cited by 7
Inpatient electronic prescribing data can be used to identify ‘lost’ discharge codes for diabetes
Nirantharakumar, K., Marshall, T. P., Hemming, K., Narendran, P., & Coleman, J. J. (2012) · Diabetic Medicine · doi:10.1111/dme.12020 · Cited by 7
A critique of the 2012 ADA/EASD position statement
Rodbard, H. W., & Jellinger, P. S. (2012) · Diabetologia · doi:10.1007/s00125-012-2646-6 · Cited by 8
Hong, D., Fort, D. G., Shi, L., & Price‐Haywood, E. G. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01096-w · Cited by 7
Gulyamova, S. T., Aziz, S. F. A., Omar, N. H., & Mohd, R. H. (2023) · Social Sciences · doi:10.3390/socsci12050275 · Cited by 7
Carpino, P. A., & Hepworth, D. (2012) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-396492-2.00012-6 · Cited by 7
Estimating medical expenditures spent on rule‐out diagnoses in Japan
Tanihara, S., Okamoto, E., & Une, H. (2011) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01601.x · Cited by 7
Asias-Dinh, B. D., Stock, E. M., Small, N. L., Getchell, K. E., Patel, J. R., Krause, J. D., Cavness, S., Dzenowski, C. L., & Ta, M. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0180-z · Cited by 7
Adriaanse, M. C., & Bosmans, J. E. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03002.x · Cited by 7
Chawla, M. S., Malve, H., Shah, H., Shinde, S., & Bhoraskar, A. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0152-3 · Cited by 7
Criteria of obesity for Asian population. Literature review
Васильевна, Б. Л. (2018) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2018-3.3.15 · Cited by 7
Tong, X., Lv, G., Huang, J., Min, Y., Yang, H. H., & Lin, P. C. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12265 · Cited by 7
Remote Quantification of Workout Energy Expenditure With a Cell Phone Camera
Yang, Y., Liu, C., Tsow, F., Shao, D., Yu, H., Xia, S., & Tao, N. J. (2016) · IEEE Sensors Journal · doi:10.1109/jsen.2016.2519906 · Cited by 9
Population Management of Diabetes in a High-Need Urban Community in the Bronx
Farrell, P. A., Barnaby, S., Galarza, T., Simonson, J. K., Zonszein, J., Meara, A., Chung, H., Figueira, R., & Felleman, S. (2013) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721713487259 · Cited by 7
Bergenstal, R. M., Freemantle, N., Leyk, M., Cutler, G. B., Hayes, R. P., & Muchmore, D. B. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0028 · Cited by 7
The Contribution of Innovation to Health Care Costs: At Least 50%?Preprint
Abrantes-Metz, R. M. (2012) · SSRN Electronic Journal · doi:10.2139/ssrn.2121688 · Cited by 7
Hen eggs as a functional food for human health: A review
Veeruraj, A., & Arumugam, M. (2025) · Food and Humanity · doi:10.1016/j.foohum.2025.100973 · Cited by 7
Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog
Young, J. R., & McAdam-Marx, C. (2010) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s5330 · Cited by 6
Ahmad, B., Khalid, B. A. K., Zaini, A. A., Hussain, N. A., & Quek, K. F. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.020 · Cited by 6
The impact of HIV-associated lipodystrophy on healthcare utilization and costs
Huang, J. S., Becerra, K., Fernandez, S., Lee, D., & Mathews, W. C. (2008) · AIDS Research and Therapy · doi:10.1186/1742-6405-5-14 · Cited by 6
Jang, Y., Park, N. S., Cho, S., Roh, S., & Chiriboga, D. A. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.03.018 · Cited by 6
Casanova, L., Bocquier, A., Cortaredona, S., Nauleau, S., Sauze, L., Sciortino, V., Villani, P., & Verger, P. (2016) · Primary care diabetes · doi:10.1016/j.pcd.2016.07.001 · Cited by 6
Dahman, L. S. B., Daakeek, A. M., Alghazali, H. S., Kaity, A. M., & Obbed, M. S. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2021.114010 · Cited by 7
Kim, H.-S., & Kim, E. J. (2022) · Healthcare · doi:10.3390/healthcare10091601 · Cited by 6
Prevalence and management of type 2 diabetes among Chinese Americans
Niu, L., Li, Y., Hwang, W., Song, G., & Xie, B. (2023) · Ethnicity and Health · doi:10.1080/13557858.2023.2179020 · Cited by 6
The Burden of Diabetes Mellitus for Medicare Beneficiaries
Costantino, M. E., Stacy, J. N., Song, F., Xu, Y., & Bouchard, J. R. (2014) · Population Health Management · doi:10.1089/pop.2013.0097 · Cited by 6
The burden of diabetes mellitus in elderly patients from an Asian tertiary hospital
Yang, Y., Goh, S., Tan, S. B., Ho, H. J. A., Emmanuel, S. C., Wang, P., & Ng, H. S. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.10.017 · Cited by 6
The future of inpatient diabetes management: glucose as the sixth vital sign
Rendell, M., Saiprasad, S., Trepp-Carrasco, A. G., & Drincic, A. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.13.1 · Cited by 6
Nutrition Trends: Implications for Diabetes Health Care Professionals
Swift, C. S. (2009) · Diabetes Spectrum · doi:10.2337/diaspect.22.1.23 · Cited by 6
Usability evaluation of web-based interfaces for Type2 Diabetes Mellitus
Davis, D., & Jiang, S. X. (2015) · International Conference on Industrial Engineering and Operations Management (IEOM) · doi:10.1109/ieom.2015.7093713 · Cited by 6
Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finland
on behalf of the FinnDiane Study Group, Lithovius, R., Harjutsalo, V., Forsblom, C. M., & Groop, P. (2010) · Diabetologia · doi:10.1007/s00125-010-1999-y · Cited by 6
Healthy Eating on a Lean Budget: Diabetes Meals for Less
Ross, T. A., & Geil, P. (2010) · Diabetes Spectrum · doi:10.2337/diaspect.23.2.120 · Cited by 6
Unidirectional or Bidirectional Relationships of Behaviors
Hernandez, D. C., & Johnston, C. A. (2016) · American Journal of Lifestyle Medicine · doi:10.1177/1559827616661971 · Cited by 6
Zarei, L., Peymani, P., Moradi, N., Kheirandish, M., Mirjalili, M., & Zare, M. (2020) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2020.152 · Cited by 6
Huang, S., Xia, X., Lai, W., Hao, X., Wu, Y., Lv, K., Luo, Z., Romão, E. A., Ciancio, G., Lv, C., et al. (2023) · Translational Andrology and Urology · doi:10.21037/tau-23-288 · Cited by 6
Costs of health. Costs-effectiveness in case of lifestyle changes
Apor, P. (2010) · Orvosi Hetilap · doi:10.1556/oh.2010.28771 · Cited by 6
Incidental risk for diabetes according to serum ferritin concentration in Korean men
Kim, S., Park, S. K., Ryoo, J., Choi, J., Hong, H. P., Park, J. H., Suh, Y. J., & Byoun, Y.-S. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.09.024 · Cited by 6
Garber, A. J. (2009) · Diabetes Care · doi:10.2337/dc09-s307 · Cited by 6
The Cost of Diabetes: A Game Changer
Lau, D. C. W. (2010) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(10)41002-3 · Cited by 6
Effective population management practices in diabetes care - an observational study
Frølich, A., Bellows, J., Nielsen, B. F., Brockhoff, P. B., & Hefford, M. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-277 · Cited by 6
Effects of 'Ubiquitous Healthcare' on the Ability of Self-Management in Elderly Diabetic Patients
Yu, S. H., Kim, S. H., Kim, S. Y., Choi, S. H., Lim, S. K., Chang, Y., Lee, H. J., Park, Y. J., & Jang, H. C. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.1.58 · Cited by 6
Unger, J. (2011) · Diabetes Therapy · doi:10.1007/s13300-010-0014-4 · Cited by 5
Oguntibeju, O. O., & Okaiyeto, K. (2021) · Plant Science Today · doi:10.14719/pst.2021.8.4.1181 · Cited by 5
Screening for Diabetes Complications during the COVID-19 Outbreak in South Korea
Park, Y. S., Kim, S.-Y., Park, E., & Jang, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095436 · Cited by 5
Metadata
- Authors
- American Diabetes Association
- Affiliations
- American Diabetes Association (US)
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-03-01
- Volume
- 31
- Issue
- 3
- Pages
- 596-615
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4246288537
- Cited by
- 1,323
- References
- 32
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 11 · 2023: 25 · 2022: 19 · 2021: 26 · 2020: 21 · 2019: 33 · 2018: 38 · 2017: 50 · 2016: 79 · 2015: 75 · 2014: 95 · 2013: 130 · 2012: 157
- FWCI
- 58.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- diabetes mellitus, economic burden of disease, health care costs, productivity loss, absenteeism, unemployment, diabetes complications, inpatient care, economic burden, diabetes prevalence, early mortality, employer-sponsored health insurance, physician visits
- MeSH terms
- Diabetes Mellitus, Humans, United States, Health Care Costs, Cost of Illness, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
